Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Clinically diagnosed patients of Kalf (Melasma) by wood’s lamp examination. 2 Patients with Fitzpatrick skin types III, IV and V 3 Patients of all sexes. 4 Patients who are willing to sign the written consent form prior to participation in the study.
Exclusion criteria
Exclusion criteria: 1 Pregnant and lactating women. 2 Patients having used any cosmetic depigmenting agent within 2 weeks prior to inclusion in the study. 3 Female on oral contraceptives and hormone therapy at the time of study. 4 Patients having used topical or systemic corticosteroid within 1 month prior to inclusion in the study. 5 Patients having history of laser treatment or dermabrasion or deep facial peels within the past 3 months. 6 Patients who have a known history or clinically relevant allergy, to any study medication components. 7 Patients who have a known history of renal insufficiency, severe liver or heart diseases, neurological disorders, malignancy, HIV infection, AIDS, etc. 8 Patients unlikely to comply with the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| • modified Melasma Area Severity Index (mMASI) • Patient Global Assessment (PtGA)Timepoint: Baseline,2nd week, 4th week and 6th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Melasma quality of life scale (MELASQoL)Timepoint: Baseline and 6th week | — |
Countries
India
Contacts
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital